Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05949034 · ClinicalTrials.gov registry record · NA
Effects of E-Cigarettes in Menthol Smokers
A NA study, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT05949034: Completed NA study, sponsored by University of Southern California.
NCT05949034 is a NA study that has completed, run by University of Southern California. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05949034, a NA study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
The current laboratory study examines e-cigarette preferences and smoking behaviors in menthol cigarette smokers.
Primary Outcome
Self-report measures of product preference will be completed following the e-cigarette self-administration. Scores can range from 0 to 100 for the preference rating, with lower scores representing less preference and higher scores representing higher preference.
Interventions
- DEVICE JUUL E-Cigarette Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2019-07-01 |
| Est. Completion | 2020-11-14 |
| Phase | NA |
What the finished NCT05949034 record still lists
NCT05949034 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which JUUL E-Cigarette Device is the first listed.
NCT05949034 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05949034 about?
NCT05949034 is a clinical study titled "Effects of E-Cigarettes in Menthol Smokers". The current laboratory study examines e-cigarette preferences and smoking behaviors in menthol cigarette smokers.
What is the current status of trial NCT05949034?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2019-07-01. Estimated completion is 2020-11-14.
What interventions are being tested in trial NCT05949034?
The interventions under investigation include: JUUL E-Cigarette Device (DEVICE).
Who is sponsoring clinical trial NCT05949034?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05949034's enrollment target sits among peer trials
19 1861st of 2000 higher than 138 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI